Ribosomal readthrough strategies for customized correction of premature termination codon mutations in skin proteins
BioTechnologia · 30.10.2026
DOI: 10.5114/bta/230952 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioTechnologia, online erschienen am 30.10.2026. Verfasst von Yllka Gashi und 9 weiteren Autor:innen. Die Arbeit nennt 107 Literaturangaben.
Abstract (Originalsprache)
The ribosome is a ribonucleoprotein complex that translates messenger RNA (mRNA) sequences into polypeptide chains. Ribosome biogenesis is a highly complex process with a pivotal role in many cellular processes, including proliferation, differentiation, apoptosis, development, and malignant transformation. Nonsense mutation introduces premature termination codons (PTCs), resulting in early termination of translation and synthesis of truncated proteins. Readthrough therapy aims to enhance suppression and consequently restore the production of full-length proteins. This approach has yielded considerable success over the years and has shown promising outcomes in many disorders associated with nonsense mutations; however, applying this approach to treat skin diseases remains challenging. This review summarizes current investigations on nonsense suppression strategies pertaining to epidermolysis bullosa. We focus on aminoglycosides that induce PTC readthrough, the small molecule PTC124 (ataluren), and inhibitors of nonsense-mediated mRNA decay. We also examine some emerging compounds that target the translational machinery and may become relevant for future nonsense mutation suppression therapy.
Zitieren
APA
Gashi, Y., Temaj, A., Nuhii, N., Xhetani, M., Nefic, H., Selmani, D., Besimi, I., Billali, S., Xharra, S., & Temaj, G. (2026). Ribosomal readthrough strategies for customized correction of premature termination codon mutations in skin proteins. BioTechnologia. https://doi.org/10.5114/bta/230952
Vancouver
Gashi Y, Temaj A, Nuhii N, Xhetani M, Nefic H, Selmani D, et al. Ribosomal readthrough strategies for customized correction of premature termination codon mutations in skin proteins. BioTechnologia. 2026. doi:10.5114/bta/230952
BibTeX
@article{Gashi2026,
author = {Gashi, Yllka and Temaj, Anjeza and Nuhii, Nexhibe and Xhetani, Merita and Nefic, Hilada and Selmani, Dritan and Besimi, Ilber and Billali, Sefedin and Xharra, Shefki and Temaj, Gazmend},
title = {Ribosomal readthrough strategies for customized correction of premature termination codon mutations in skin proteins},
journal = {BioTechnologia},
year = {2026},
doi = {10.5114/bta/230952}
}
EUVIMED